Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy-Reference-Cited by-同舟云学术

Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy

Published:2018-01-26 Issue:3 Volume:67 Page:972-988
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Fiorotto Romina¹²,Amenduni Mariangela¹,Mariotti Valeria³,Fabris Luca³,Spirli Carlo¹²,Strazzabosco Mario¹²

Affiliation:

1. Section of Digestive Diseases, Liver Center; Yale University; New Haven CT

2. International Center for Digestive Health; University of Milan-Bicocca; Milan Italy

3. Department of Molecular Medicine; University of Padua, School of Medicine; Padua Italy

Funder

National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health

Silvio O. Conte Digestive Diseases Research Core Centers

Fondazione Fibrosi Cistica

PSC Partners Seeking a Cure Foundation

Publisher

Wiley

Subject

Hepatology

Reference45 articles.

1. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA;Riordan;Science,1989

2. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis;Kinnman;Hepatology,2000

3. Cystic fibrosis;Rowe;N Engl J Med,2005

4. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome;Colombo;Hepatology,2002

5. Natural history of liver disease in cystic fibrosis;Lindblad;Hepatology,1999

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice;Journal of Hepatology;2024-09

2. Pathophysiology of Cystic Fibrosis Liver Disease;Pediatric Pulmonology;2024-08-06

3. SHIFTing goals in cystic fibrosis—managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium;Pediatric Pulmonology;2024-04-12

4. Diagnosis, Management, and Prognosis of Cystic Fibrosis-Related Liver Disease in Children;Diagnostics;2024-03-03

5. From CFTR to a CF signalling network: a systems biology approach to study Cystic Fibrosis;2023-11-17